Benjamin Winograd
Impact in
- Oncology top 2%
- Cancer Treatment and Pharmacology
- HER2/EGFR in Cancer Research
- Peptidase Inhibition and Analysis
- Viral-associated cancers and disorders
- Hematology top 2%
- Multiple Myeloma Research and Treatments
Papers in
- Oncology 35
- Cancer Treatment and Pharmacology 16
- Lung Cancer Research Studies 7
-
- Cancer therapeutics and mechanisms 17
- Co-authors
- Herbert M. Pinedo (10 shared papers)J van Ark-Otte (3 shared papers)Godefridus J. Peters (4 shared papers)Paulo Eduardo Pizão (1 shared paper)Renzo Canetta (4 shared papers)P. Fumoleau (1 shared paper)M. Bontenbal (1 shared paper)Jacques Bonneterre (1 shared paper)
- Journals
- Journal of Clinical Oncology (10 papers)European Journal of Cancer (5 papers)British Journal of Cancer (4 papers)Cancer Chemotherapy and Pharmacology (3 papers)Neuro-Oncology Advances (1 paper)
- Partner nations
- NetherlandsUnited StatesGermany
In The Last Decade
Benjamin Winograd
56 papers receiving 2.3k citations
Benjamin Winograd's Hit Papers
Peers
Comparison fields: 5 of 108
- Oncology 1.2k
- Hematology 462
- Cancer Research 260
- Genetics 124
- Molecular Biology 850
Countries citing papers authored by Benjamin Winograd
This map shows the geographic impact of Benjamin Winograd's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benjamin Winograd with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benjamin Winograd more than expected).
Fields of papers citing papers by Benjamin Winograd
This network shows the impact of papers produced by Benjamin Winograd. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benjamin Winograd. The network helps show where Benjamin Winograd may publish in the future.
Co-authors
The 25 scholars most cited alongside Benjamin Winograd, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 57 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1991 | 410 | |
| 2 | Lenalidomide Maintenance After Autologous Stem-Cell Transplantation in Newly Diagnosed Multiple Myeloma: A Meta-Analysis Hit paper breakdown → | 2017 | 409 |
| 3 | 1996 | 342 | |
| 4 | 1999 | 146 | |
| 5 | Phase II preclinical drug screening in human tumor xenografts: a first European multicenter collaborative study. | 1992 | 80 |
| 6 | 1999 | 80 | |
| 7 | Comparative pharmacokinetics of cisplatin and three analogues in mice and humans. | 1987 | 77 |
| 8 | Overview of Taxol safety. | 1993 | 66 |
| 9 | 2001 | 65 | |
| 10 | 1991 | 52 | |
| 11 | High-dose paclitaxel with granulocyte colony-stimulating factor in patients with advanced breast cancer refractory to anthracycline therapy: a European Cancer Center trial. | 1995 | 47 |
| 12 | European-Canadian randomized trial of Paclitaxel in relapsed ovarian cancer: high-dose versus low-dose and long versus short infusion | 1998 | 44 |
| 13 | 1990 | 36 | |
| 14 | 1988 | 35 | |
| 15 | 1993 | 34 | |
| 16 | 1988 | 32 | |
| 17 | Human tumor xenografts in the nude mouse and their value as test models in anticancer drug development (review). | 1992 | 30 |
| 18 | 1992 | 29 | |
| 19 | 2021 | 29 | |
| 20 | 1996 | 26 |
About Benjamin Winograd
Benjamin Winograd is a scholar working on Oncology, Molecular Biology, Epidemiology, Genetics and Pathology and Forensic Medicine, having authored 57 papers that have together received 2.4k indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (17 papers), Cancer Treatment and Pharmacology (16 papers), Lung Cancer Research Studies (7 papers), Chemotherapy-induced organ toxicity mitigation (5 papers), Chemotherapy-related skin toxicity (5 papers), Neuroendocrine Tumor Research Advances (5 papers), Monoclonal and Polyclonal Antibodies Research (4 papers) and Multiple Myeloma Research and Treatments (4 papers). The work is most often cited by research in Oncology (1.2k citations), Hematology (462 citations), Cancer Research (260 citations), Genetics (124 citations) and Molecular Biology (850 citations). Benjamin Winograd has collaborated with scholars based in Netherlands, United States and Germany. Frequent co-authors include Herbert M. Pinedo, J van Ark-Otte, Godefridus J. Peters, Paulo Eduardo Pizão, Renzo Canetta, P. Fumoleau, M. Bontenbal, Jacques Bonneterre, G. Catimel and PierFranco Conte. Their work appears in journals such as Journal of Clinical Oncology, European Journal of Cancer, British Journal of Cancer, Cancer Chemotherapy and Pharmacology and Neuro-Oncology Advances.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.